Helix BioPharma Corp. Provides Bi-Weekly MCTO Status Update

RICHMOND HILL, ON / ACCESSWIRE / November 1, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment

Related Keywords

Canada , Toronto , Ontario , Richmond Hill , Canadian , Frank Michalargias , Toronto Stock Exchange , Helix Biopharma Corp , Ontario Securities Commission Under National , Helix Biopharma , Ontario Securities Commission , National Policy , Cease Trade Orders , Default Announcement , Annual Filings , Chief Financial , Looking Statements , Annual Information Form , Helix , Iopharma , Orp , Rovides , Weekly , Cto , Status , Update ,